LLY

754.8

+2.95%↑

JNJ

154.98

+0.66%↑

UNH

379.64

-0.19%↓

ABBV

191.89

+4.15%↑

ABT

133.55

+0.22%↑

LLY

754.8

+2.95%↑

JNJ

154.98

+0.66%↑

UNH

379.64

-0.19%↓

ABBV

191.89

+4.15%↑

ABT

133.55

+0.22%↑

LLY

754.8

+2.95%↑

JNJ

154.98

+0.66%↑

UNH

379.64

-0.19%↓

ABBV

191.89

+4.15%↑

ABT

133.55

+0.22%↑

LLY

754.8

+2.95%↑

JNJ

154.98

+0.66%↑

UNH

379.64

-0.19%↓

ABBV

191.89

+4.15%↑

ABT

133.55

+0.22%↑

LLY

754.8

+2.95%↑

JNJ

154.98

+0.66%↑

UNH

379.64

-0.19%↓

ABBV

191.89

+4.15%↑

ABT

133.55

+0.22%↑

Search

Maravai LifeSciences Holdings Inc (Class A)

Abierto

2.05 3.54

Resumen

Variación precio

24h

Actual

Mínimo

2.01

Máximo

2.11

Métricas clave

By Trading Economics

Ingresos

53M

-46M

Ventas

-8.8M

56M

BPA

-0.02

Margen de beneficio

-82.429

Empleados

570

EBITDA

127M

-21M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+180.81% upside

Dividendos

By Dow Jones

Próximas Ganancias

12 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

90M

756M

Apertura anterior

-1.49

Cierre anterior

2.05

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Maravai LifeSciences Holdings Inc (Class A) Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

11 may 2025, 23:48 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Dyno Nobel Returns to 1st Half Profit; Strikes Fertilizers Deals -- Update

11 may 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S.-China Trade Talks -- Market Talk

11 may 2025, 23:45 UTC

Charlas de Mercado

Oil Rises Amid Improved Market Mood -- Market Talk

11 may 2025, 23:38 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Aristocrat Has Significant Firepower for M&A -- Market Talk

11 may 2025, 23:36 UTC

Charlas de Mercado

Global Markets Uncertain About US-China Trade News -- Market Talk

11 may 2025, 23:35 UTC

Charlas de Mercado

Gold Falls, Dragged by Weakening Safe-Haven Demand, Possible Profit-Taking -- Market Talk

11 may 2025, 23:33 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Dyno Nobel Returns to 1H Profit; Strikes Fertilizers Deals -- Update

11 may 2025, 23:32 UTC

Principales Noticias

Proposal Cutting Medicaid Aims for GOP Middle Ground -- WSJ

11 may 2025, 22:44 UTC

Charlas de Mercado

Centaurus Metals's Jaguar Project Faces Funding Hurdles -- Market Talk

11 may 2025, 22:33 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Domain Takeover Could Create Near-Term Overhang on REA Stock -- Market Talk

11 may 2025, 20:19 UTC

Principales Noticias

Bessent Says U.S.-China Trade Talks Were 'Productive,' Without Offering Specifics -- WSJ

11 may 2025, 16:00 UTC

Principales Noticias

Trump's Budget Hawk Takes Over the DOGE Agenda. First Up: the Military -- WSJ

11 may 2025, 11:00 UTC

Principales Noticias

This Obscure New York Court Is Set to Decide Fate of Trump's Tariffs -- WSJ

11 may 2025, 08:00 UTC

Principales Noticias

China's Property Market Is a Tale of Big Cities. Everywhere Else Is Struggling. -- Barrons.com

11 may 2025, 01:00 UTC

Principales Noticias

The Spring Home Sales Season Is Shaping Up to Be a Dud -- WSJ

11 may 2025, 01:00 UTC

Principales Noticias

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia on Cease-Fire -- WSJ

10 may 2025, 21:54 UTC

Principales Noticias

GOP Tax Bill Seeks to Put Cash in Taxpayers' Pockets in Early 2026 -- Update

10 may 2025, 17:12 UTC

Principales Noticias

Europe Threatens Nord Stream 2 Sanctions to Pressure Russia to Cease Fire -- WSJ

10 may 2025, 15:41 UTC

Principales Noticias

Fed Officials Signal Pause on Adjusting Interest Rates as Trade Risks Mount -- Barrons.com

10 may 2025, 12:00 UTC

Principales Noticias

Why a Sorority Is Taking on Trump's Budget Cuts -- WSJ

10 may 2025, 09:30 UTC

Principales Noticias

The Giants of Silicon Valley Are Having a Midlife Crisis Over AI -- WSJ

10 may 2025, 08:20 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

10 may 2025, 03:52 UTC

Principales Noticias

China Struggles With Persistent Disinflationary Pressures as Tariffs Bite -- WSJ

9 may 2025, 23:51 UTC

Adquisiciones, fusiones, absorciones

Oil at $50? The High Cost of Cheap Crude. -- Barrons.com

9 may 2025, 22:06 UTC

Charlas de Mercado

Arm Holdings Remains a Strong Growth Story -- Market Talk

9 may 2025, 21:37 UTC

Principales Noticias

U.S. Sets August Deadline for Debt Ceiling -- WSJ

9 may 2025, 21:10 UTC

Principales Noticias

The Score: Disney, Berkshire Hathaway, Ford and More Stocks That Defined the Week -- WSJ

9 may 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

9 may 2025, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

9 may 2025, 20:42 UTC

Principales Noticias

Stocks Get a Break From Trade Chaos -- WSJ

Comparación entre iguales

Cambio de precio

Maravai LifeSciences Holdings Inc (Class A) Esperado

Precio Objetivo

By TipRanks

180.81% repunte

Estimación a 12 meses

Media 5.56 USD  180.81%

Máximo 10 USD

Mínimo 2.5 USD

De acuerdo con 10 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Maravai LifeSciences Holdings Inc (Class A) Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

10 ratings

6

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

2.02 / 2.115Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

No Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Maravai LifeSciences Holdings Inc (Class A)

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.